Search Results - Trias, Esteve

The hospital exemption pathway for the approval of advanced therapy medicinal products: an underused opportunity? The case of the CAR-T ARI-0001 by Trias, Esteve, Juan, Manel, Urbano-Ispizua, Alvaro, Calvo, Gonzalo

Get full text Get full text Get full text

Critical pathway for deceased tissue donation: a novel adaptative European systematic approach by Sandiumenge, Alberto, Domínguez‐Gil, Beatriz, Pont, Teresa, Sánchez Ibáñez, Jacinto, Chandrasekar, Akila, Bokhorst, Arlinke, Filipe Severino, Paulo, Oliveira, Josefina, Boergel, Martin, Ponzin, Diego, Trias, Esteve

Get full text Get full text Get full text

Transplantation of Human Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium in a Swine Model of Geographic Atrophy by Duarri, Anna, Rodríguez-Bocanegra, Eduardo, Martínez-Navarrete, Gema, Biarnés, Marc, García, Miriam, Ferraro, Lucía Lee, Kuebler, Bernd, Aran, Begoña, Izquierdo, Elisabeth, Aguilera-Xiol, Eli, Casaroli-Marano, Ricardo P., Trias, Esteve, Fernandez, Eduardo, Raya, Ángel, Veiga, Anna, Monés, Jordi

Get full text Get full text Get full text

Immune tolerance in multiple sclerosis and neuromyelitis optica with peptide-loaded tolerogenic dendritic cells in a phase 1b trial by Zubizarreta, Irati, Flórez-Grau, Georgina, Vila, Gemma, Cabezón, Raquel, España, Carolina, Andorra, Magi, Saiz, Albert, Llufriu, Sara, Sepulveda, Maria, Sola-Valls, Nuria, Martinez-Lapiscina, Elena H., Pulido-Valdeolivas, Irene, Casanova, Bonaventura, Martinez Gines, Marisa, Tellez, Nieves, Oreja-Guevara, Celia, Español, Marta, Trias, Esteve, Cid, Joan, Juan, Manel, Lozano, Miquel, Blanco, Yolanda, Steinman, Lawrence, Benitez-Ribas, Daniel, Villoslada, Pablo

Get full text Get full text Get full text

Point-Of-Care CAR T-Cell Production (ARI-0001) Using a Closed Semi-automatic Bioreactor: Experience From an Academic Phase I Clinical Trial by Castella, Maria, Caballero-Baños, Miguel, Ortiz-Maldonado, Valentín, González-Navarro, Europa Azucena, Suñé, Guillermo, Antoñana-Vidósola, Asier, Boronat, Anna, Marzal, Berta, Millán, Lucía, Martín-Antonio, Beatriz, Cid, Joan, Lozano, Miquel, García, Enric, Tabera, Jaime, Trias, Esteve, Perpiña, Unai, Canals, Josep Ma, Baumann, Tycho, Benítez-Ribas, Daniel, Campo, Elías, Yagüe, Jordi, Urbano-Ispizua, Álvaro, Rives, Susana, Delgado, Julio, Juan, Manel

Get full text Get full text Get full text

Development of a Novel Anti-CD19 Chimeric Antigen Receptor: A Paradigm for an Affordable CAR T Cell Production at Academic Institutions by Castella, Maria, Boronat, Anna, Martín-Ibáñez, Raquel, Rodríguez, Vanina, Suñé, Guillermo, Caballero, Miguel, Marzal, Berta, Pérez-Amill, Lorena, Martín-Antonio, Beatriz, Castaño, Julio, Bueno, Clara, Balagué, Olga, González-Navarro, Europa Azucena, Serra-Pages, Carles, Engel, Pablo, Vilella, Ramon, Benitez-Ribas, Daniel, Ortiz-Maldonado, Valentín, Cid, Joan, Tabera, Jaime, Canals, Josep M., Lozano, Miquel, Baumann, Tycho, Vilarrodona, Anna, Trias, Esteve, Campo, Elías, Menendez, Pablo, Urbano-Ispizua, Álvaro, Yagüe, Jordi, Pérez-Galán, Patricia, Rives, Susana, Delgado, Julio, Juan, Manel

Get full text Get full text Get full text

CART19-BE-01: A Multicenter Trial of ARI-0001 Cell Therapy in Patients with CD19(+) Relapsed/Refractory Malignancies by Ortíz-Maldonado, Valentín, Rives, Susana, Castellà, Maria, Alonso-Saladrigues, Anna, Benítez-Ribas, Daniel, Caballero-Baños, Miguel, Baumann, Tycho, Cid, Joan, Garcia-Rey, Enric, Llanos, Cristina, Torrebadell, Montserrat, Villamor, Neus, Giné, Eva, Díaz-Beyá, Marina, Guardia, Laia, Montoro, Mercedes, Català, Albert, Faura, Anna, González, E. Azucena, Español-Rego, Marta, Klein-González, Nela, Alsina, Laia, Castro, Pedro, Jordan, Iolanda, Fernández, Sara, Ramos, Federico, Suñé, Guillermo, Perpiñá, Unai, Canals, Josep M., Lozano, Miquel, Trias, Esteve, Scalise, Andrea, Varea, Sara, Sáez-Peñataro, Joaquín, Torres, Ferran, Calvo, Gonzalo, Esteve, Jordi, Urbano-Ispizua, Álvaro, Juan, Manel, Delgado, Julio

Get full text Get full text Get full text

Factors associated with the clinical outcome of patients with relapsed/refractory CD19(+) acute lymphoblastic leukemia treated with ARI-0001 CART19-cell therapy by Ortiz-Maldonado, Valentín, Rives, Susana, Español-Rego, Marta, Alonso-Saladrigues, Anna, Montoro, Mercedes, Magnano, Laura, Giné, Eva, Pascal, Mariona, Díaz-Beyá, Marina, Castella, Maria, Català, Albert, Faura, Anna, Rodríguez-Lobato, Luis Gerardo, Oliver-Caldes, Aina, Martínez-Roca, Alexandra, Rovira, Montserrat, González-Navarro, E Azucena, Ortega, Juan Ramón, Cid, Joan, Lozano, Miquel, Garcia-Rey, Enric, Fernández, Sara, Castro, Pedro, Jordan, Iolanda, Villamor, Neus, Aymerich, Marta, Torrebadell, Montserrat, Deyà, Àngela, Fernández de Larrea, Carlos, Benitez-Ribas, Daniel, Trias, Esteve, Varea, Sara, Calvo, Gonzalo, Esteve, Jordi, Urbano-Ispizua, Alvaro, Juan, Manel, Delgado, Julio

Get full text Get full text Get full text